Pacific Edge Limited (PEB.AX)
AUD 0.08
(0.0%)
AUD 0.08
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 46.44 Million NZD | -14.04% |
| 2023 | 54.03 Million NZD | 60.66% |
| 2022 | 33.63 Million NZD | 36.06% |
| 2021 | 24.71 Million NZD | 2.12% |
| 2020 | 24.2 Million NZD | 5.07% |
| 2019 | 23.03 Million NZD | -8.4% |
| 2018 | 25.15 Million NZD | -17.58% |
| 2017 | 30.51 Million NZD | 33.43% |
| 2016 | 22.86 Million NZD | 53.89% |
| 2015 | 14.86 Million NZD | 37.74% |
| 2014 | 10.78 Million NZD | 45.23% |
| 2013 | 7.42 Million NZD | 57.19% |
| 2012 | 4.72 Million NZD | 41.24% |
| 2011 | 3.34 Million NZD | -3.18% |
| 2010 | 3.45 Million NZD | 7.93% |
| 2009 | 3.2 Million NZD | 33.75% |
| 2008 | 2.39 Million NZD | 2.02% |
| 2007 | 2.34 Million NZD | -26.99% |
| 2006 | 3.21 Million NZD | 7.75% |
| 2005 | 2.98 Million NZD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 10.74 Million NZD | 0.0% |
| 2024 Q1 | 12.47 Million NZD | 0.88% |
| 2024 Q2 | 12.47 Million NZD | 0.0% |
| 2024 Q3 | 10.74 Million NZD | -13.9% |
| 2024 FY | 65.56 Million NZD | 21.35% |
| 2023 Q4 | 12.36 Million NZD | 0.0% |
| 2023 FY | 54.03 Million NZD | 60.66% |
| 2023 Q3 | 12.36 Million NZD | 48.4% |
| 2023 Q2 | 8.33 Million NZD | 0.0% |
| 2023 Q1 | 8.33 Million NZD | 12.39% |
| 2022 Q2 | 6.07 Million NZD | 0.0% |
| 2022 Q3 | 7.41 Million NZD | 22.16% |
| 2022 Q4 | 7.41 Million NZD | 0.0% |
| 2022 FY | 33.63 Million NZD | 36.06% |
| 2022 Q1 | 6.07 Million NZD | 24.2% |
| 2021 Q2 | 4.15 Million NZD | 0.0% |
| 2021 Q1 | 4.15 Million NZD | -12.35% |
| 2021 Q4 | 4.88 Million NZD | 0.0% |
| 2021 FY | 24.71 Million NZD | 2.12% |
| 2021 Q3 | 4.88 Million NZD | 17.68% |
| 2020 Q3 | 4.73 Million NZD | 0.67% |
| 2020 FY | 24.2 Million NZD | 5.07% |
| 2020 Q4 | 4.73 Million NZD | 0.0% |
| 2020 Q2 | 4.7 Million NZD | 0.0% |
| 2020 Q1 | 4.7 Million NZD | -15.21% |
| 2019 Q3 | 5.55 Million NZD | 51.26% |
| 2019 FY | 23.03 Million NZD | -8.4% |
| 2019 Q1 | 3.67 Million NZD | -6.79% |
| 2019 Q4 | 5.55 Million NZD | 0.0% |
| 2019 Q2 | 3.67 Million NZD | 0.0% |
| 2018 Q1 | 3.81 Million NZD | 47.54% |
| 2018 FY | 25.15 Million NZD | -17.58% |
| 2018 Q4 | 3.93 Million NZD | 0.0% |
| 2018 Q2 | 3.81 Million NZD | 0.0% |
| 2018 Q3 | 3.93 Million NZD | 3.12% |
| 2017 Q3 | 2.58 Million NZD | -56.7% |
| 2017 Q4 | 2.58 Million NZD | 0.0% |
| 2017 FY | 30.51 Million NZD | 33.43% |
| 2017 Q2 | 5.97 Million NZD | 0.0% |
| 2017 Q1 | 5.97 Million NZD | 19.69% |
| 2016 FY | 22.86 Million NZD | 53.89% |
| 2016 Q4 | 4.99 Million NZD | 0.0% |
| 2016 Q1 | 3.66 Million NZD | -34.33% |
| 2016 Q2 | 3.66 Million NZD | 0.0% |
| 2016 Q3 | 4.99 Million NZD | 36.13% |
| 2015 Q4 | 5.58 Million NZD | 0.0% |
| 2015 FY | 14.86 Million NZD | 37.74% |
| 2015 Q3 | 5.58 Million NZD | 1920.59% |
| 2015 Q2 | 276.49 Thousand NZD | 0.0% |
| 2015 Q1 | 276.49 Thousand NZD | -76.73% |
| 2014 Q2 | 2.57 Million NZD | 0.0% |
| 2014 Q1 | 2.57 Million NZD | 344.93% |
| 2014 FY | 10.78 Million NZD | 45.23% |
| 2014 Q4 | 1.18 Million NZD | 0.0% |
| 2014 Q3 | 1.18 Million NZD | -53.89% |
| 2013 Q3 | 579.18 Thousand NZD | 0.0% |
| 2013 Q4 | 579.18 Thousand NZD | 0.0% |
| 2013 FY | 7.42 Million NZD | 57.19% |
| 2012 FY | 4.72 Million NZD | 41.24% |
| 2011 FY | 3.34 Million NZD | -3.18% |
| 2010 FY | 3.45 Million NZD | 7.93% |
| 2009 FY | 3.2 Million NZD | 33.75% |
| 2008 FY | 2.39 Million NZD | 2.02% |
| 2007 FY | 2.34 Million NZD | -26.99% |
| 2006 FY | 3.21 Million NZD | 7.75% |
| 2005 FY | 2.98 Million NZD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Australian Clinical Labs Limited | 81.54 Million AUD | 43.044% |
| BCAL Diagnostics Limited | 8.54 Million AUD | -443.528% |
| Genetic Signatures Limited | 4.3 Million AUD | -978.134% |
| Genetic Technologies Limited | 3.9 Million AUD | -1089.558% |
| Healius Limited | 265.1 Million AUD | 82.48% |
| Imagion Biosystems Limited | 15.53 Million AUD | -198.987% |
| Integral Diagnostics Limited | 61.88 Million AUD | 24.953% |
| INOVIQ Ltd | 6.8 Million AUD | -582.348% |
| Microba Life Sciences Limited | 5.9 Million AUD | -686.497% |
| Monash IVF Group Limited | 91.1 Million AUD | 49.022% |
| Rhythm Biosciences Limited | 5.34 Million AUD | -768.171% |
| Sonic Healthcare Limited | 1.49 Billion AUD | 96.895% |